CVS (CVS - Get Report)  recently announced plans to acquire Aetna (AET) for $69 billion in a move that is widely seen as an unprecedented merger of retail and healthcare.

But is the potential combo a reaction to Amazon's (AMZN - Get Report) dive into healthcare? Amazon recently obtained wholesale distribution licenses from pharmaceutical boards in multiple states, including New Jersey, Connecticut, Michigan and Arizona. It's also reportedly in preliminary talks with generic drugmakers including Mylan NV and Sandoz (NVS - Get Report) The question is, what will the master of disruption do next?

It's your move, Jeff Bezos. 

More of What's Trending on TheStreet:

 

N/A